215 related articles for article (PubMed ID: 23190531)
1. Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease.
Kögl T; Müller J; Jessen B; Schmitt-Graeff A; Janka G; Ehl S; zur Stadt U; Aichele P
Blood; 2013 Jan; 121(4):604-13. PubMed ID: 23190531
[TBL] [Abstract][Full Text] [Related]
2. Distinct severity of HLH in both human and murine mutants with complete loss of cytotoxic effector PRF1, RAB27A, and STX11.
Sepulveda FE; Debeurme F; Ménasché G; Kurowska M; Côte M; Pachlopnik Schmid J; Fischer A; de Saint Basile G
Blood; 2013 Jan; 121(4):595-603. PubMed ID: 23160464
[TBL] [Abstract][Full Text] [Related]
3. Syntaxin 11 is required for NK and CD8⁺ T-cell cytotoxicity and neutrophil degranulation.
D'Orlando O; Zhao F; Kasper B; Orinska Z; Müller J; Hermans-Borgmeyer I; Griffiths GM; Zur Stadt U; Bulfone-Paus S
Eur J Immunol; 2013 Jan; 43(1):194-208. PubMed ID: 23042080
[TBL] [Abstract][Full Text] [Related]
4. Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients.
Bryceson YT; Rudd E; Zheng C; Edner J; Ma D; Wood SM; Bechensteen AG; Boelens JJ; Celkan T; Farah RA; Hultenby K; Winiarski J; Roche PA; Nordenskjöld M; Henter JI; Long EO; Ljunggren HG
Blood; 2007 Sep; 110(6):1906-15. PubMed ID: 17525286
[TBL] [Abstract][Full Text] [Related]
5.
Benavides N; Spessott WA; Sanmillan ML; Vargas M; Livingston MS; Erickson N; Pozos TC; McCormick ME; Scharrig E; Messinger YH; Giraudo CG
Front Immunol; 2020; 11():545414. PubMed ID: 33162974
[TBL] [Abstract][Full Text] [Related]
6. Unusual functional manifestations of a novel STX11 frameshift mutation in two infants with familial hemophagocytic lymphohistiocytosis type 4 (FHL4).
Macartney CA; Weitzman S; Wood SM; Bansal D; Steele M; Meeths M; Abdelhaleem M; Bryceson YT
Pediatr Blood Cancer; 2011 Apr; 56(4):654-7. PubMed ID: 21298754
[TBL] [Abstract][Full Text] [Related]
7. Polygenic mutations in the cytotoxicity pathway increase susceptibility to develop HLH immunopathology in mice.
Sepulveda FE; Garrigue A; Maschalidi S; Garfa-Traore M; Ménasché G; Fischer A; de Saint Basile G
Blood; 2016 Apr; 127(17):2113-21. PubMed ID: 26864340
[TBL] [Abstract][Full Text] [Related]
8. Munc18-2 is required for Syntaxin 11 Localization on the Plasma Membrane in Cytotoxic T-Lymphocytes.
Dieckmann NM; Hackmann Y; Aricò M; Griffiths GM
Traffic; 2015 Dec; 16(12):1330-41. PubMed ID: 26771955
[TBL] [Abstract][Full Text] [Related]
9. Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion.
Spessott WA; Sanmillan ML; McCormick ME; Patel N; Villanueva J; Zhang K; Nichols KE; Giraudo CG
Blood; 2015 Mar; 125(10):1566-77. PubMed ID: 25564401
[TBL] [Abstract][Full Text] [Related]
10. SM protein Munc18-2 facilitates transition of Syntaxin 11-mediated lipid mixing to complete fusion for T-lymphocyte cytotoxicity.
Spessott WA; Sanmillan ML; McCormick ME; Kulkarni VV; Giraudo CG
Proc Natl Acad Sci U S A; 2017 Mar; 114(11):E2176-E2185. PubMed ID: 28265073
[TBL] [Abstract][Full Text] [Related]
11. IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis.
Humblet-Baron S; Franckaert D; Dooley J; Bornschein S; Cauwe B; Schönefeldt S; Bossuyt X; Matthys P; Baron F; Wouters C; Liston A
J Allergy Clin Immunol; 2016 Jul; 138(1):200-209.e8. PubMed ID: 26947179
[TBL] [Abstract][Full Text] [Related]
12. IFN-γ and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis.
Humblet-Baron S; Franckaert D; Dooley J; Ailal F; Bousfiha A; Deswarte C; Oleaga-Quintas C; Casanova JL; Bustamante J; Liston A
J Allergy Clin Immunol; 2019 Jun; 143(6):2215-2226.e7. PubMed ID: 30578871
[TBL] [Abstract][Full Text] [Related]
13. Syntaxin 11 marks a distinct intracellular compartment recruited to the immunological synapse of NK cells to colocalize with cytotoxic granules.
Dabrazhynetskaya A; Ma J; Guerreiro-Cacais AO; Arany Z; Rudd E; Henter JI; Karre K; Levitskaya J; Levitsky V
J Cell Mol Med; 2012 Jan; 16(1):129-41. PubMed ID: 21342435
[TBL] [Abstract][Full Text] [Related]
14. A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice.
Sepulveda FE; Maschalidi S; Vosshenrich CA; Garrigue A; Kurowska M; Ménasche G; Fischer A; Di Santo JP; de Saint Basile G
Blood; 2015 Feb; 125(9):1427-34. PubMed ID: 25525117
[TBL] [Abstract][Full Text] [Related]
15. Trigger-dependent differences determine therapeutic outcome in murine primary hemophagocytic lymphohistiocytosis.
Gather R; Aichele P; Goos N; Rohr J; Pircher H; Kögl T; Zeiser R; Hengel H; Schmitt-Gräff A; Weaver C; Ehl S
Eur J Immunol; 2020 Nov; 50(11):1770-1782. PubMed ID: 32419134
[TBL] [Abstract][Full Text] [Related]
16. Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production.
Chiang SC; Theorell J; Entesarian M; Meeths M; Mastafa M; Al-Herz W; Frisk P; Gilmour KC; Ifversen M; Langenskiöld C; Machaczka M; Naqvi A; Payne J; Perez-Martinez A; Sabel M; Unal E; Unal S; Winiarski J; Nordenskjöld M; Ljunggren HG; Henter JI; Bryceson YT
Blood; 2013 Feb; 121(8):1345-56. PubMed ID: 23287865
[TBL] [Abstract][Full Text] [Related]
17. Digenic Inheritance: Evidence and Gaps in Hemophagocytic Lymphohistiocytosis.
Steen EA; Hermiston ML; Nichols KE; Meyer LK
Front Immunol; 2021; 12():777851. PubMed ID: 34868048
[TBL] [Abstract][Full Text] [Related]
18. A CD57
Hori M; Yasumi T; Shimodera S; Shibata H; Hiejima E; Oda H; Izawa K; Kawai T; Ishimura M; Nakano N; Shirakawa R; Nishikomori R; Takada H; Morita S; Horiuchi H; Ohara O; Ishii E; Heike T
J Clin Immunol; 2017 Jan; 37(1):92-99. PubMed ID: 27896523
[TBL] [Abstract][Full Text] [Related]
19. The exocytosis of lytic granules is impaired in Vti1b- or Vamp8-deficient CTL leading to a reduced cytotoxic activity following antigen-specific activation.
Dressel R; Elsner L; Novota P; Kanwar N; Fischer von Mollard G
J Immunol; 2010 Jul; 185(2):1005-14. PubMed ID: 20543108
[TBL] [Abstract][Full Text] [Related]
20. Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis.
Johnson TS; Terrell CE; Millen SH; Katz JD; Hildeman DA; Jordan MB
J Immunol; 2014 Jan; 192(1):84-91. PubMed ID: 24259502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
